Accurately capturing the prevalence of hrp2/3 deletion within a population is paramount to public health policies, particularly as the WHO recommends that areas with >5% prevalence of hrp2 deletion should implement non–HRP2-based RDTs for malaria diagnostics [1]. Here, HDGFL2 is linked to malaria.